Immunotherapy heralds ‘new era’ for cancer treatment

by Honor Whiteman A “whole new era” for cancer treatment is upon us, according to experts. Two new studies published in the New England Journal of Medicine provide further evidence that immunotherapy – the use of drugs to stimulate immune response – is highly effective against the disease. Recently presented at the 2015 American Society for Clinical Oncology...

Read More

First presentation of data from NEUPRO (rotigotine transdermal patch) Phase 3 study in China announced

UCB has announced efficacy and safety data from a Phase 3 study evaluating NEUPRO® (rotigotine transdermal patch) in the treatment of patients in China with early-stage Parkinson’s disease (PD).1 Results showed that rotigotine significantly improved activities of daily living and motor function compared with placebo. The adverse event profile observed in this population...

Read More

New obesity drug gives 6 kg extra weight loss in trial

Markus MacGill 6 July 2015 at 7am PST diabetes drug approved in December 2014 for the treatment of obesity has shown promise in a trial of weight loss efficacy published in The New England Journal of Medicine Used at a higher dose than recommended for type 2 diabetes, liraglutide (sold by Novo Nordisk as Saxenda), taken as an adjunct to diet and exercise,...

Read More

Canadian Multiple Sclerosis research update

Learn the latest news on Canadian MS research. MS Research delivers exciting updates on advancements in the field, stories from the MS research community and profiles on world-leading MS researchers.In the latest issue, find out more about Canadian researcher Dr. David Haegert’s work with the Progressive MS Alliance, stem cells and MS research and the...

Read More

Cancer Treatment Can Reactivate Hepatitis B

By Yasmine Iqbal For cancer patients who have previously been infected with the hepatitis B virus, some chemotherapy or immunosuppressive treatments could potentially reactivate their infection. The U.S. Food and Drug Administration called attention to the problem in September 2013 when it required warning labels about the potential hepatitis B reactivation to be placed...

Read More

RESEARCHERS IDENTIFY NEW GENE RESPONSIBLE FOR LIVER DISEASE.

Acute liver failure is a rare yet life-threatening disease for young children. It often occurs extremely rapidly, for example, when a child has a fever. Yet in around 50 percent of cases it is unclear as to why this happens. Now, a team of researchers working on an international research project headed by Technische Universität München (TUM), the Helmholtz Zentrum Munich...

Read More